semaglutide approved for obesity Semaglutide- weight loss in Kids approved for weight loss
Description
Obesity affects 42% of adults in the United States and is strongly associated with major cardiovascular disease risk factors, including high blood pressure, abnormal cholesterol levels, and insulin resistance, making effective obesity treatment a critical public health priority.
The FDAs recent decision to remove semaglutide from the drug shortage list marks a significant shift for compounding pharmacies
These drugs work by mimicking a gut hormone that slows digestion and reduces appetite, leading to significant weight loss in many patients
Starting dose medication in English packaging for diabetes treatment.
